Status:
UNKNOWN
Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Corneal Transplantation
Glaucoma and Ocular Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Common complications of the Boston keratoprosthesis type 1 (KPro) surgery include retroprosthetic membrane formation, glaucoma, and retinal detachment. Often pars plana vitrectomy (PPV) is performed a...
Detailed Description
Boston keratoprosthesis type 1 (KPro) surgery is the most common corneal graft and is used to restore vision in patients with high risk of failure with traditional penetrating keratoplasty. Common com...
Eligibility Criteria
Inclusion
- Aged from 18 to 80 years old
- Informed consent
- Boston keratoprosthesis candidate
- Pars plana vitrectomy candidate
- Ability to be followed for the duration of the study
Exclusion
- Aged less than 18 or more than 80 years old
- Inability to give informed consent
- Repeat Boston keratoprosthesis
- Repeat pars plana vitrectomy
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04337944
Start Date
April 8 2020
End Date
March 1 2025
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4